spironolactone has been researched along with Ovarian Diseases in 2 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
Ovarian Diseases: Pathological processes of the OVARY.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gayral, MN | 1 |
Millet, D | 1 |
Netter, A | 1 |
Adashi, EY | 1 |
1 review available for spironolactone and Ovarian Diseases
Article | Year |
---|---|
Potential utility of gonadotropin-releasing hormone agonists in the management of ovarian hyperandrogenism.
Topics: Androgen Antagonists; Androgens; Biomechanical Phenomena; Contraceptives, Oral; Drug Therapy, Combin | 1990 |
1 other study available for spironolactone and Ovarian Diseases
Article | Year |
---|---|
[Ovarian hyperstimulation syndrome. Notes on the physiopathology and treatment apropos of 3 cases].
Topics: Adult; Ascites; Capillary Permeability; Chorionic Gonadotropin; Female; Gonadotropins, Pituitary; Hu | 1975 |